ALNY
$246.74-2.89%
as of close, Sep 30, 2026
☾ AH $246.74 -2.89%
Alnylam Pharmaceuticals Inc.Stock · Health CareNasdaq-100 0.2%Nasdaq Composite 0.09%Russell 1000 0.06%US Stock Market 0.06%Russell 3000 0.06%MSCI World 0.04%MSCI ACWI 0.03%
Alnylam Pharmaceuticals Inc. returns by year
As of market close, Sep 30, 2026
Alnylam Pharmaceuticals Inc. returns by year (2005–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $397.65 | $246.74 | 0.0% | -38.0% | |
| 2025 | $235.31 | $397.65 | 0.0% | +69.0% | |
| 2024 | $191.41 | $235.31 | 0.0% | +22.9% | |
| 2023 | $237.65 | $191.41 | 0.0% | -19.5% | |
| 2022 | $169.58 | $237.65 | 0.0% | +40.1% | |
| 2021 | $129.97 | $169.58 | 0.0% | +30.5% | |
| 2020 | $115.17 | $129.97 | 0.0% | +12.9% | |
| 2019 | $72.91 | $115.17 | 0.0% | +58.0% | |
| 2018 | $127.05 | $72.91 | 0.0% | -42.6% | |
| 2017 | $37.44 | $127.05 | 0.0% | +239.3% | |
| 2016 | $94.14 | $37.44 | 0.0% | -60.2% | |
| 2015 | $97.00 | $94.14 | 0.0% | -2.9% | |
| 2014 | $64.30 | $97.00 | 0.0% | +50.9% | |
| 2013 | $18.25 | $64.30 | 0.0% | +252.3% | |
| 2012 | $8.15 | $18.25 | 0.0% | +123.9% | |
| 2011 | $9.86 | $8.15 | 0.0% | -17.3% | |
| 2010 | $17.62 | $9.86 | 0.0% | -44.0% | |
| 2009 | $24.73 | $17.62 | 0.0% | -28.8% | |
| 2008 | $29.08 | $24.73 | 0.0% | -15.0% | |
| 2007 | $21.40 | $29.08 | 0.0% | +35.9% | |
| 2006 | $13.32 | $21.40 | 0.0% | +60.7% | |
| 2005 | $7.47 | $13.32 | 0.0% | +78.3% |
- Annualized
- +17.0%
- 2005–2026
- Average year
- +40.2%
- 21 full years
- Best year
- +252.3%
- 2013
- Worst year
- -60.2%
- 2016
- Positive years
- 13/21
- 62% up
Annualized (CAGR)
+17.0%
2005–2026
Average year
+40.2%
21 full years
Best year
+252.3%
2013
Worst year
-60.2%
2016
Positive years
13/21
62% up
Total return by period#
Annual
-200%-100%0%100%200%
2005+78%'05
2006+61%
2007+36%'07
2008-15%
2009-29%'09
2010-44%
2011-17%'11
2012+124%
2013+252%'13
2014+51%
2015-2.9%'15
2016-60%
2017+239%'17
2018-43%
2019+58%'19
2020+13%
2021+30%'21
2022+40%
2023-19%'23
2024+23%
2025+69%'25
2026-38%
Methodology#
Total returns, dividends reinvested, measured on ALNY. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Alnylam Pharmaceuticals Inc.'s average annual return?
- Since 2005, Alnylam Pharmaceuticals Inc. (ALNY) has returned about 17.0% a year (the compound annual growth rate) and an average calendar-year return of 40.2%.
- What were Alnylam Pharmaceuticals Inc.'s best and worst years?
- Over 2005–2026, the best year was 2013 (+252.3%) and the worst was 2016 (-60.2%).
- How often is Alnylam Pharmaceuticals Inc. up in a year?
- 13 of the 21 full years since 2005 were positive — about 62% of the time.
More on Alnylam Pharmaceuticals Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100